Crossmark

Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis

Crossref DOI link: https://doi.org/10.1016/j.arbr.2020.08.015

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lopez-Lopez, Lidia

Cabrera Cesar, Eva

Lara, Estrella

Hidalgo-San Juan, M. Victoria

Parrado, Concepcion

Martín-Montañez, Elisa

Garcia-Fernandez, Maria
License Information

Text and Data Mining valid from 2021-03-01
More Information

This article is maintained by: Elsevier

Article Title: Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2020.08.015

Content Type: simple-article

Copyright: © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.